Clearance of the original hepatitis B virus YMDD‐motif mutants with emergence of distinct lamivudine‐resistant mutants during prolonged lamivudine therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|31|6|1318-1326

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.31, Iss.6, 2000-06, pp. : 1318-1326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adefovir Dipivoxil for Treatment of Breakthrough Hepatitis Caused by Lamivudine-Resistant Mutants of Hepatitis B Virus

By  

Intervirology, Vol. 47, Iss. 6, 2004-11 ,pp. : 362-369

Karger

Access to resources Recommend Favorite

Histological Improvements after a Three-Year Lamivudine Therapy in Patients with Chronic Hepatitis B in Whom YMDD Mutants Did Not or Did Develop

By  

Intervirology, Vol. 46, Iss. 3, 2003-07 ,pp. : 164-170

Karger

Access to resources Recommend Favorite

Subclones of Drug-Resistant Hepatitis B Virus Mutants and the Outcome of Breakthrough Hepatitis in Patients Treated with Lamivudine

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite

Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil

By  

Intervirology, Vol. 51, Iss. 6, 2009-02 ,pp. : 385-393

Karger

Access to resources Recommend Favorite